METHYL (2S,3R,4S,5R,6S)-6-(5-((S)-2-(3-CYCLOPROPOXY-4-DIFLUOROMETHOXYPHENYL)-2-(6-(1-HYDROXY-1-METHYLETHYL)-3-PYRIDYL)ETHYL)-2-PYRIDYLOXY)-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-CARBOXYLATE
UNII AGJ6N4CX7M
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl (2s,3r,4s,5r,6s)-6-(5-((s)-2-(3-cyclopropoxy-4-difluoromethoxyphenyl)-2-(6-(1-hydroxy-1-methylethyl)-3-pyridyl)ethyl)-2-pyridyloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AGJ6N4CX7M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2750575-21-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H36F2N2O10 HYKKOSPPALHLPV-QASFHVGWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl (2s,3r,4s,5r,6s)-6-(5-((s)-2-(3-cyclopropoxy-4-difluoromethoxyphenyl)-2-(6-(1-hydroxy-1-methylethyl)-3-pyridyl)ethyl)-2-pyridyloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.